Retraction of COVID-19 Pharmacoepidemiology Research Could Have Been Avoided by Effective Use of Reporting Guidelines

INTRODUCTION: Two recent high-profile publications (and subsequent retractions) of pharmacoepidemiology studies reporting the effectiveness and risk of hydroxychloroquine in COVID-19 patients received international media attention. Transparent and complete reporting of these studies could have provi...

Descripción completa

Detalles Bibliográficos
Autores principales: Benchimol, Eric I, Moher, David, Ehrenstein, Vera, Langan, Sinéad M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762449/
https://www.ncbi.nlm.nih.gov/pubmed/33376409
http://dx.doi.org/10.2147/CLEP.S288677

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762449/
https://www.ncbi.nlm.nih.gov/pubmed/33376409
http://dx.doi.org/10.2147/CLEP.S288677

Ejemplares similares